Drugs / Pigmanorm
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05165524 Comparator | Mar 2022 → Jan 2025 | hyperpigmentation of the skin, varicose disease | Insel Gruppe AG, University Hospital Bern | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pigmanorm | “Patients will be treated with a triple brightening cream (Pigmanorm®), applied daily, three times per week for 12 weeks on the lesion.” NCT05165524 ↗ |
| Route | Topical | “applied daily, three times per week for 12 weeks on the lesion” NCT05165524 ↗ |